Claim
descriptive

When the IP6K1 gene is removed in mouse brain cells, the brief electrical pause after each firing becomes longer and deeper, indicating that sodium-potassium pumps may play a previously unrecognized role in shaping how neurons reset after signaling.

Evidence from Studies

No evidence studies found yet.

What Would Prove This

Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.

1
Systematic Reviews & Meta-Analyses

A systematic review would determine whether NKA modulation consistently alters fast AHP across species and conditions, and whether IP6K1 inhibition is the most reliable method to achieve this effect.

A systematic review and meta-analysis of all published studies measuring fast AHP duration and amplitude in response to NKA modulation (genetic, pharmacological, or antibody-based) in neurons from rodents, primates, and human iPSC-derived neurons.

2
Randomized Controlled Trials

An RCT in mice could determine whether pharmacological inhibition of NKA reverses the extended fast AHP observed in IP6K1 knockout neurons, confirming NKA as the mediator.

A double-blind, randomized crossover trial in 20 IP6K1 KO mice, where each mouse receives intracellular perfusion of ouabain (NKA inhibitor) vs. vehicle during patch-clamp recording, with primary outcome of fast AHP amplitude and duration before and after intervention.

3
Cohort Studies

A cohort study could determine whether the magnitude of fast AHP deepening in IP6K1 KO mice correlates with reduced seizure susceptibility across different genetic backgrounds.

A longitudinal cohort study of 100 IP6K1 KO mice across 5 different genetic strains, measuring fast AHP amplitude via patch-clamp at 8, 12, and 16 weeks, and correlating with seizure threshold induced by pentylenetetrazol challenge.

4
Case-Control Studies

A case-control study could determine whether mice with mutations in NKA subunits that mimic IP6K1 deletion also show extended fast AHP, supporting NKA as the key effector.

A case-control study comparing fast AHP in 30 IP6K1 KO mice to 30 mice with ATP1A1 gain-of-function mutations and 30 wild-type controls, all tested under identical electrophysiological conditions.

5
Cross-Sectional Studies
In Evidence

A cross-sectional analysis of brain tissue could determine whether fast AHP depth correlates with NKA levels in IP6K1 KO mice across different cortical layers.

A cross-sectional analysis of 40 IP6K1 KO and 40 WT mice, measuring fast AHP amplitude via patch-clamp and NKA protein levels via immunofluorescence in layers II/III, V, and VI of the somatosensory cortex, with correlation analysis.

Sign up to see full verdict